MedTrace Logo

Colombia Epidemiologic Surveillance Study

NCT00428051 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 32867

Last updated 2011-10-27

No results posted yet for this study

Summary

The study will determine the reduction in invasive pneumococcal disease (IPD) after the introduction of a National Immunization Program with PCV-7 in Bogota. The original LEAP study determine incidence of IPD prior to introduction of PCV-7 in Brazil, Costa Rica and Colombia. LEAP II is the continuation of the study in Colombia only.

Conditions

Interventions

OTHER

Surveillance

No study drug, only interventions are blood draws and Chest X-rays

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
28 Days
Max Age
36 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2011-02-28
Completion
2011-10-31

Countries

  • Brazil
  • Colombia
  • Costa Rica

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00428051 on ClinicalTrials.gov